Autolus Therapeutics (AUTL) Deferred Taxes (2020 - 2025)
Autolus Therapeutics (AUTL) posted quarterly Deferred Taxes of $1.2 million for Q4 2025, up 929.79% year-on-year from $113615.7 in Q4 2024, and up 9100.0% on a QoQ basis from -$13000.0 in Q3 2025.
Autolus Therapeutics (AUTL) Deferred Taxes (2020 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Deferred Taxes for 6 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.
- Quarterly Deferred Taxes rose 929.79% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $286000.0 (up 54.59% YoY) and the FY2025 annual result came in at $286000.0, up 54.59% from the prior year.
- Deferred Taxes climbed to $1.2 million in Q4 2025 per AUTL's latest filing, from -$13000.0 in the prior quarter.
- Over the last five years, Deferred Taxes for AUTL reached as high as $1.2 million in Q4 2025 and fell as low as -$487000.0 in Q1 2025.
- A 5-year average of $89850.0 and a median of $164000.0 in 2022 frame the typical range for Deferred Taxes.
- The largest YoY upside for Deferred Taxes was 929.79% in 2025 against a maximum downside of 418.92% in 2025.
- Year by year, Deferred Taxes stood at $420000.0 in 2021, then plunged by 175.95% to -$319000.0 in 2022, then surged by 246.08% to $466000.0 in 2023, then sank by 130.26% to -$141000.0 in 2024, then soared by 929.79% to $1.2 million in 2025.
- According to Business Quant data, Deferred Taxes over the past three periods registered $1.2 million, -$13000.0, and -$384000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -384,000.00 |
| Mar 31, 2025 | -487,000.00 |
| Dec 31, 2024 | -141,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Jun 30, 2024 | -74,000.00 |
| Mar 31, 2024 | 232,000.00 |
| Dec 31, 2023 | 466,000.00 |
| Sep 30, 2023 | 238,000.00 |
| Jun 30, 2023 | 87,000.00 |
| Mar 31, 2023 | 195,000.00 |
| Dec 31, 2022 | -319,000.00 |
| Sep 30, 2022 | 160,000.00 |
| Jun 30, 2022 | 253,000.00 |
| Mar 31, 2022 | 174,000.00 |
| Dec 31, 2021 | 420,000.00 |
| Sep 30, 2021 | -233,000.00 |
| Jun 30, 2021 | -395,000.00 |
| Mar 31, 2021 | 280,000.00 |